Citigroup’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Sell |
8,340
-8,858
| -52% | -$73.3K | ﹤0.01% | 3879 |
|
|
2025
Q1 | $110K | Sell |
17,198
-1,428
| -8% | -$9.14K | ﹤0.01% | 3786 |
|
|
2024
Q4 | $115K | Buy |
18,626
+1,392
| +8% | +$8.59K | ﹤0.01% | 3922 |
|
|
2024
Q3 | $85.6K | Buy |
17,234
+10,557
| +158% | +$52.4K | ﹤0.01% | 4061 |
|
|
2024
Q2 | $41.1K | Buy |
6,677
+1,986
| +42% | +$12.2K | ﹤0.01% | 3966 |
|
|
2024
Q1 | $52.3K | Buy |
4,691
+1,994
| +74% | +$22.2K | ﹤0.01% | 3857 |
|
|
2023
Q4 | $31K | Buy |
2,697
+2,587
| +2,352% | +$29.7K | ﹤0.01% | 4037 |
|
|
2023
Q3 | $823 | Sell |
110
-5,294
| -98% | -$39.6K | ﹤0.01% | 4365 |
|
|
2023
Q2 | $50.7K | Sell |
5,404
-13,186
| -71% | -$124K | ﹤0.01% | 3966 |
|
|
2023
Q1 | $151K | Buy |
18,590
+1,742
| +10% | +$14.2K | ﹤0.01% | 3256 |
|
|
2022
Q4 | $163K | Buy |
+16,848
| New | +$163K | ﹤0.01% | 3142 |
|
|
2021
Q2 | – | Sell |
-1,441
| Closed | -$9K | – | 5487 |
|
|
2021
Q1 | $9K | Sell |
1,441
-2,700
| -65% | -$16.9K | ﹤0.01% | 5021 |
|
|
2020
Q4 | $30K | Buy |
4,141
+3,113
| +303% | +$22.6K | ﹤0.01% | 4402 |
|
|
2020
Q3 | $6K | Sell |
1,028
-1,872
| -65% | -$10.9K | ﹤0.01% | 4548 |
|
|
2020
Q2 | $24K | Buy |
2,900
+1,782
| +159% | +$14.7K | ﹤0.01% | 4133 |
|
|
2020
Q1 | $7K | Buy |
+1,118
| New | +$7K | ﹤0.01% | 4718 |
|
|
2019
Q4 | – | Sell |
-1,308
| Closed | -$6K | – | 5121 |
|
|
2019
Q3 | $6K | Sell |
1,308
-465
| -26% | -$2.13K | ﹤0.01% | 4728 |
|
|
2019
Q2 | $8K | Sell |
1,773
-1,540
| -46% | -$6.95K | ﹤0.01% | 4794 |
|
|
2019
Q1 | $16K | Buy |
3,313
+267
| +9% | +$1.29K | ﹤0.01% | 4603 |
|
|
2018
Q4 | $19K | Sell |
3,046
-153
| -5% | -$954 | ﹤0.01% | 4430 |
|
|
2018
Q3 | $26K | Buy |
3,199
+1,571
| +96% | +$12.8K | ﹤0.01% | 4416 |
|
|
2018
Q2 | $17K | Buy |
+1,628
| New | +$17K | ﹤0.01% | 4447 |
|